Shanghai Ji Ai Genetics & IVF Institute, Obstetrics and Gynecology Hospital of Fudan University
Shanghai, Shanghai Municipality, 200011, China
NCT Number: NCT03994614
Patients in experimental group will be given transcutaneous electrical acupoint stimulation (TEAS) treatment for 12 weeks prior to controlled ovarian stimulation (COS).The patients will be given three times acupuncture every week except menstruation.Patients in no intervention group will not be given any interventions for 12 weeks prior to COS. The primary outcome measure is the number of MII eggs obtained in the COS cycle. The secondary outcome measures are the lab and clinical reproductive outcomes.
Looking for future studies?
Notify Me20 year–45 year
Female
Interventional
Not applicable
Shanghai, Shanghai Municipality, 200011, China
The patients will be randomly recruited into two groups. Patients in experimental group will be given TEAS treatment for 12 weeks prior to COS.The patients will be given three times acupuncture every week except menstruation. One treatment lasts for 30 minutes. The acupoints used for the TEAS treatment included head acupoint Baihui(DU20), abdominal acupoint Zhongji (RN3), Guanyuan (RN4), Zigong(EX-CA1), leg acupoint Sanyinjiao(SP6), waist acupoint Shenyu (BL23) and Guanyuanyu(BL26). Patients in no intervention group will not be given any intervention for 12 weeks prior to COS. When at least one dominant follicle is greater than 18 mm then injection a GnRH agonist (Triptorelin, Ferring, Switzerland) 0.2mg. 36 hours later transvaginal oocyte retrieval will be taken. After 3 hours of incubation, each egg will be transferred with a density of about 100,000/mllive sperm. The fresh embryo transfer is performed 72 hours after embryo culture in vitro. The whole embryos will be frozen.
The primary outcome measure is the number of MII eggs obtained in the COS cycle. The secondary outcome measures are the lab and clinical reproductive outcomes,including basic endocrine, serum Anti-Mullerian Hormone (AMH), antral follicle counts, fertilization rate, cleavage rate, number of D3 embryos, the clinical pregnancy rate and early abortion rate.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients in the experimental group will be given TEAS treatment for 12 weeks prior to COS. The patients will be given three times acupuncture every week except menstruation. The acupuncture acupoint locations are as follows: head acupoint Baihui(DU20), abdominal acupoint Zhongji (RN3), Guanyuan (RN4), Zigong(EX-CA1), leg acupoint Sanyinjiao(SP6), waist acupoint Shenyu (BL23) and Guanyuanyu(BL26).
Time frame: one day after oocyte pickup
The number of MII eggs obtained in the COS cycle
Time frame: On Day two of menstruation
Basic FSH value in mIU/ml
Time frame: On Day two of menstruation
Basic LH in mIU/ml
Time frame: On Day two of menstruation
Basic estrodiol in pg/ml
Time frame: On Day two of menstruation
Serum AMH in ng/ml
Time frame: antral follicle count On Day two of menstruation
antral follicle count
Time frame: fertilization rate calculated on 1 day after oocyte pickup
fertilization rate
Time frame: cleavage rate calculated on 2 days after oocyte pickup
cleavage rate
Time frame: the number of Day 3 embryos calculated on 3 days after oocyte pickup
the number of Day 3 embryos
Time frame: clinical pregnancy rate calculated on the 6th gestational week
clinical pregnancy rate
Time frame: early abortion rate calculated on 12th week of pregnancy
early abortion rate
ShangHai Ji Ai Genetics & IVF Institute
Other
The Clinical Trial of the Effect of Transcutaneous Electrical Acupoint Stimulation on the Quality of the Oocyte on Poor Ovarian Response
Acronym: POR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06617988
Poor Ovarian Response
Jinan, Shandong, China
View Trial DetailsNCT07085312
Female Infertility of Other Origin, Oocyte Immaturity
Caracas, Distrito Federal, Venezuela
View Trial DetailsNCT04013984
Accupuncture, Poor Ovarian Response
Tehran, Iran
View Trial DetailsNCT05703308
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Tehran, Iran
View Trial Details